⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TSHA News
Taysha Gene Therapies, Inc. Common Stock
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
globenewswire.com
TSHA
Sapanisertib Market Size Analysis and Sales Forecast 2020-2034: Commercial Outlook Hinges on Late-Stage Success
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Form 8-K
sec.gov
TSHA
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TSHA
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
globenewswire.com
TSHA
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
globenewswire.com
TSHA
Form 8-K
sec.gov
TSHA